Recently, point mutations at 2 codons of the highly preserved a-chain of G,, the adenyl cyclase-stimulating G-protein, were found in GHsecreting pituitary tumors. These mutations resulted in constitutively activated G,a and high intracellular CAMP levels. In addition, point mutations at similar codons of a different G-protein, G,o12, were reported in adrenocortical neoplasms, suggesting a potential role of this isoform in the genesis of these tumors.
We reevaluated the frequency of constitutively activating point mutations in the a-chain of the stimulatory (G,ol) and inhibitory (Gicu2) G-proteins in human adrenocortical tumors. Seven adrenocortical carcinomas, 2 human adrenocortical tumor cell lines, and 11 adrenocortical adenomas were studied.
Genomic DNA was purified from either frozen tumor tissue or paraffinembedded sections.
Using specific primers and the polymerase chain reaction, DNA fragments surrounding codons 201 and 227 (G,oc) and 179 and 205 (G,a2) were amplified and visualized on a 2% agarose gel. In a second asymmetric polymerase chain reaction, using nested primers, single stranded DNA was generated using l-10 FL of the initial amplification mixture and directly sequenced using the dideoxy chain termination method of Sanger. We found no mutations at codons 201, 227 and 179, 205 of G,a and G,a2, respectively, in the tumors studied. We conclude that previously identified oncogenic point mutations in the stimulatory and inhibitory a-chain of G-proteins do not appear to be present at high frequency in adrenal neoplasms. Thus, the mechanism(s) of tumorigenesis in these tumors is different from that in GH-secreting adenomas and may involve oncogenic mutations of other cell constituents.
(J Clin Endocrinol Metab '7'7: 1419-1422,1993) T WO DECADES ago, adrenocortical neoplasms were considered rare. However, with wider application of ultrasound, computed tomography, and, more recently, magnetic resonance imaging, it became evident that the prevalence of clinically silent, incidentally detected adrenal neoplasms is much higher than previously assumed (1) . However, the tumorigenesis of adrenocortical neoplasms is not well understood, and the molecular mechanisms that lead to adrenal tumor formation have not been extensively studied.
G-Proteins involved in signal transduction are heterotrimers consisting of cy-, P-, and y-subunits that bind guanine nucleotide and interact with specific receptors and effecters (2) . G-Protein activation normally requires the interaction of the inactive GDP-bound heterotrimer with a ligand-occupied receptor, resulting in the exchange of GTP for GDP and dissociation of the a-unit (3) . Recently, mutations in the (Yunit of G,, the adenylyl cyclase-stimulating protein, have been described in GH-secreting pituitary adenomas (4). These mutations caused an amino acid exchange at the highly conserved codons Arg*" and Gln227, resulting in a constitu-tive activation of G,a by inhibition of endogenous GTPase activity. These putative oncogenic mutations, which were called Gsp, were found in approximately 40% of GH-producing tumors and 4% of thyroid tumors (5, 6) . Point mutations at similar codons of a different G-protein, codons 179 and 205 of G,a2, were reported in adrenocortical neoplasms, suggesting a potential role of mutated Gi(u2 (Gip 2) in the tumorigenesis of adrenocortical masses (5) . However, the initially described series was rather small (n = ll), demonstrating mutations in three (27%) tumors. We, therefore, reevaluated the frequency of Gsp and Gip 2 in a larger series of adrenocortical tumors.
Subjects and Methods
Isolation of DNA from tissue specimens T WO DECADES ago, adrenocortical neoplasms were considered rare, However, with wider application of ultrasound, computed tomography, and, more recently, magnetic resonance imaging, it became evident that the prevalence of clinically silent, incidentally detected adrenal neoplasms is much high er than previously assumed (1), However, the tumorigenesis of adrenocortical neoplasms is not wen understood, and the molecular mechanisms that lead to adrenal tumor formation have not been extensively studied.
G-Proteins involved in signal transduction are heterotrimers consisting of a-, ß-, and ')'-subunits that bind guanine nucleotide and interact with specific receptors and effectors (2), G-Protein activation normally requires the interaction of the inactive GDP-bound heterotrimer with a ligand-occupied receptor, resulting in the exchange of GTP for GDP and dissociation of the a-unit (3), Recently, mutations in the aunit of GS! the adenylyl cyclase-stimulating pro tein, have been described in GH-secreting pituitary adenomas (4), These mutations caused an amino acid exchange at the highly conserved co dons Arg 201 and Gln
227
, resulting in a constitu- (5), However, the initially described series was rather small (n = 11), demonstrating mutations in three (27%) tumors, We, therefore, reevaluated the frequency of Gsp and Gip 2 in a larger series of adrenocortical tumors,
Subjects and Methods

Isolation of DNA from tissue specimens
Adrenocortical tumor tissue was obtained at adrenalectomy from 18 patients, DNA was isolated from 7 adrenocortical cardnomas and 11 adrenocortical adenomas (for clinical data, see Table 1 ), In 10 cases, tumor DNA was extracted from paraffin-embedded seetions accumula ted over a 30-yr pcriod. In 8 ca ses, frozen (-80 C) tumor tissue and corresponding normal leukocytic DNA were studied, In addition, DNA from the 2 currently available human adrenocortical tumor cell lines were studied, SW13, a nonsecretory human adrenocortical tumor cell line maintained in Ham's F-10 medium with 10% fetal bovine serum, was received from the American Type Culture Collection (Rockville, MD), NCl H-295, a human steroid-producing adrenocortical tumor JCE & M .1993 Vol7l.No5 
Results
In all but two cases, DNA fragments surrounding codons 201 and 227 of G,LY and codons 179 and 205 of Gia2 were successfully amplified by PCR and showed the predicted size on agarose gel electrophoresis. In two 31-and 32-yr-old paraffin-embedded tumor specimens, the 299-and 350-bp long fragments surrounding codons 201 and 227 could not be amplified, probably due to DNA degradation, whereas the shorter fragments surrounding codons 179 (168 bp) and 205 (195 bp) could be efficiently amplified in these cases.
Direct sequencing of the PCR product from normal leukocyte DNA revealed the wild-type sequence for the amplified regions. All adrenal adenomas, all adrenocortical carcinomas, and the two adrenocortical tumor cell lines showed only the wild-type sequence at codons 201 and 227 of G,a and codons 179 and 205 of Gia2 (Table 2 and Fig. 1 ). In addition, no mutations were found at other codons of G,a and G,o12 in these amplifications.
Discussion
Constitutively activating mutations in G-proteins were found in several endocrine neoplasms. Adenylcyclase activity was extremely elevated under basal conditions in these tumors (12) . Clinically, the GH-secreting adenomas were smaller in diameter, less responsive to GH-releasing-hormone, and more sensitive to somatostatin-and dopamineinduced GH inhibition than adenomas with no mutated G, celliine maintained in HITES (containing hydrocortisone, insulin, ethanolamine and selenite) medium with 2% fetal bovine, was kindly provided by Dr. E. Gazdar (7).
DNA preparation
DNA was iso la ted from paraffin-embedded specimens (8), leukocytes, or frozen tumor seetions obtained at surgery (9), as previously described. Tissue sampies were derived from a central portion of the tumor to minimize the possibility of contamination with normal tissue. Representative seetions of the tumor material were examined by light microseopy and shown to eonsist of more than 90% tumor cells. For paraffinembedded specimens, 10-ILm sections were carefully cut and placed in sterile Eppendorf tubes using new gloves, forceps, and a cleaned microtome blade for every tumor block. . Special precautions were taken to avoid contamination of the PCR sampies. In all PCR experiments, sampies containing no DNA were included as negative controls. The amplification protocol consisted of denaturation at 95 C for 5 min, followed by 30-40 cycles consisting of annealing at 55 C for 1.5 min, primer extension at 72 C for 1.5 min, and denaturation at 94 C for 1 min. All amplified sam pies were examined by agarose gel electrophoresis to confirm successful amplification of each of the regions of the G,a and G i a2 genes.
Polymerase chain reaction (PCR) amplification of genomic DNA
PCR
Direct sequencing of the PCR product
In a second, asymmetrie PCR, using one of the nested primers in a 100-fold excess, single stranded DNA was generated, purified on Ultrapure MC filters (Millipore, Bedford, MA), and lyophilized at room temperature. Using the dideoxy chain termination method of Sanger et al. (11) , the PCR product was sequenced (T7-DNA polymerase, Sequenase 2.0, U.S. Biochemical Corp., Cleveland, OH) with [a-
35 S]deoxy-ATP and run on a 6% denaturing polyacrylamide gel. Autoradiography was performed with Kodak XAR 2 films (Eastman Kodak, Roehester, NY).
Results
In all but two cases, DNA fragments surrounding codons 201 and 227 of Gsa and codons 179 and 205 of Gja2 were successfully amplified by PCR and showed the predicted size on agarose gel electrophoresis. In two 31-and 32-yr-old paraffin-embedded tumor specimens, the 299-and 350-bp long fragments surrounding co dons 201 and 227 could not be amplified, probably due to DNA degradation, whereas the shorter fragments surrounding codons 179 (168 bp) and 205 (195 bp) could be efficiently amplified in these cases.
Direct sequencing of the PCR product from normal leukocyte DNA revealed the wild-type sequence for the amplified regions. All adrenal adenomas, all adrenocortical carcinomas, and the two adrenocortical tumor cell lines showed only the wild-type sequence at codons 201 and 227 of Gsa and codons 179 and 205 of Ga2 (Table 2 and Fig. 1 ). In addition, no mutations were found at other co dons of Gsa and Gja2 in these amplifications.
Discussion
Constitutively activating mutations in G-proteins were found in several endocrine neoplasms. Adenylcyclase activity was extremely elevated under basal conditions in these tumors (12) . Clinically, the GH-secreting adenomas were smaller in diameter, less responsive to GH-releasing-hormone, and more sensitive to somatostatin-and dopamineinduced GH inhibition than adenomas with no mutated G s using PCR and oligonucleotide-specific hybridization. Although the functional significance of these putative oncogenie mutations Gip 2 was not proven, several indirect lines of evidence suggested, promotion of cell proliferation by constitutively activated Gia2. However, using PCR and direct sequencing, we were unable to confirm the results of Lyons et al. None of 7 adrenal carcinomas and 11 adenomas showed mutations at codons 179 and 205 of Gia2. In addition, although oncogenic mutations are generally more frequent in human tumor cell lines than in tumor tissue, the 2 currently available human adrenocortical tumor cell lines had wildtype sequences at codons 179 and 205 of Gia2. The differences between our results and the data of Lyons et al. cannot be explained by the different methodologies used in these studies. Direct sequencing of PCR-amplified DNA fragments is equally sensitive in detecting point mutations in the tumor genome compared to allele-specific oligonucleotide hybridization, which was used by Lyons et al. More likely, our data suggest that the putative oncogene Gip 2 does not play a major role in the tumorigenesis of human adrenocortical neoplasias.
Several recent publications suggested that oncogenes other than Gip 2 are involved in adrenocortical tumor formation. Yano ef al. (16) consistently showed loss of constitutional heterozygosity for alleles at chromosomes llq, 13q, and 17p in adrenocortical carcinomas, but not in adrenal adenomas or hyperplastic adrenal lesions. Chromosome llq seems to be important in adrenal tumorigenesis. 1 lq13 is the locus of the multiple endocrine neoplasia-1 tumor suppressor gene (17) , and adrenal tumor formation is part of this entity. However, the deletion of the chromosomal region llq13 present in parathyroid and pancreatic tumors (17) is not always present in adrenal tumors of these patients (18) . The Wiedemann-Beckwith syndrome, which is associated with allelic loss of 1 lq15, is characterized by early development of Wilm's tumors and adrenocortical carcinomas (19) . Chromosome 13 is the locus of the retinoblastoma gene (20) ; however, no studies have been reported elucidating the pathophysiological significance of retinoblastoma gene mutations in adrenal neoplasms. The short arm of chromosome 17 contains the p53 gene, which is most frequently known to be mutated in human cancer (21) . A germ-line mutation in the p53 gene is associated with the Li-Fraumeni syndrome in cancer-prone families (22) whose members may develop adrenocortical carcinoma (23) . In summary, these data together with our results show that molecular mechanisms different from the previously suggested oncogenes Gsp and Gip 2 are involved in the tumorigenesis of adrenocortical neoplasms. (12) (13) (14) . Somatic mu tations in G,a were also found in benign and malignant thyroid neoplasms. Lyons el aI. (5) reported a low incidence of Gsp mutations in thyroid neoplasms (1 of 25 cases), whereas Suarez cl aI. (6) found constitutively activating mutations of G.", in 10% of thyroid tumors. Goretzki el al. (15) reported Gsp mutations in all 25 multinodular goiters studied from an iodine-deficienl area, but in none of 3 thyroid adenomas. The Gsp mutations were multifocally distributed throughout the tissue. These researchers, therefore, concluded that the Gsp oncogene constituted one of Ihe genetic bases of this disease. Whereas Gsp is imporlant in endocrine tumors, it d oes not playa role in the pathogenesis of other neoplasms. No Gsp mutations were found in 21 8 nonenclocrine tu mors studied, including breast, colon, and gastric carcinomas (5 Several recent publications suggested that oncogenes other than Gip 2 are involved in adrenocortical tumor formation . Yano el al. (16) consistently showed lass of constitutional heterozygosity for alleles at chromosomes 11q, 13q, and 17p in adrenocortical carcinomas, but not in adrenal adenomas or h yperplastic adrenal lesions. Chromosome 11q seems to be important in adrenal tumorigenesis. 11q13 is the locus of the multiple endocrine neoplasia-l tumor suppressor gene (17) , and adrenal tumor formation is part of this entity. However, the deletion of the chromosomal region 11 q 13 present in parathyroid and pancrea tic tumors (17) is not al ways present in adrenal tumors of these patients (18) . The Wiedemann-Beckwith syndrome, which is associated with alle lic loss of l1q 15, is characterized by early development of Wilm 's tumors and adrenocortieal cardnomas (19) . Chromosome 13 is the locus of the retinoblastoma gene (20) ; however, no studies have been reported elucidating the pathophysiological significance of retinoblastoma gene mutations in adrenal neoplasms. The shorl arm of chromosome 17 contains the pS3 gene, which is most frequently known to be mutated in h uman cancer (21) . A germ-line mutation in the p53 gene is associated with the Li-Fraumeni syndrome in cancer-prone families (22) whose members may develop adrenocortical carcinoma (23) . In summary, these data together with our results show that molecular mechanisms d ifferent from the previously suggested oncogenes Gsp and Gip 2 are involved in the tu morigenesis of adrenocortical neoplasms. 
